Company Filing History:
Years Active: 2022-2025
Title: Gary Pitt: Innovator in Rho-Associated Protein Kinase Modulation
Introduction
Gary Pitt is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of rho-associated protein kinases. With a total of 3 patents to his name, Pitt's work is focused on developing novel compounds that can aid in the treatment of various diseases.
Latest Patents
One of Gary Pitt's latest patents involves modulators of rho-associated protein kinase. This invention relates to novel compounds and pharmaceutical compositions that comprise these compounds. The compounds are particularly useful as modulators of Rho-associated protein kinase (ROCK), specifically as ROCK1 and/or ROCK2 inhibitors. The methods of treatment employing these compounds are also contemplated by the present invention. These compounds are beneficial in treating ROCK-mediated diseases.
Career Highlights
Gary Pitt is currently associated with Redx Pharma Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of diseases related to rho-associated protein kinases.
Collaborations
Throughout his career, Gary has collaborated with notable colleagues such as Peter Bunyard and Liam Byrne. These collaborations have further enriched his research and development efforts in the field.
Conclusion
In summary, Gary Pitt is a distinguished inventor whose work in the modulation of rho-associated protein kinases has the potential to impact the treatment of various diseases significantly. His contributions to the pharmaceutical field are noteworthy and continue to inspire innovation.